Hydroxocobalamin: Improved public health readiness for cyanide disasters

Annals of Emergency Medicine

Volumn 37, Issue 6, 2001, Pages 635-641

  Sauer, Samual W ^a   Keim, Mark E ^b,c  

^a UNIVERSITY OF HAWAII   (United States)

^b NATIONAL CENTER FOR ENVIRONMENTAL HEALTH   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYL NITRITE; ANTIDOTE; COBALT EDETATE; CYANIDE; HYDROXOCOBALAMIN; NITROPRUSSIDE SODIUM; SODIUM NITRITE; SODIUM THIOSULFATE; THIOSULFATE;

ARTICLE; CLINICAL TRIAL; CYANIDE POISONING; DISASTER; DRUG CLEARANCE; DRUG COMPETITION; DRUG DISTRIBUTION; DRUG EFFECT; DRUG EFFICACY; DRUG HALF LIFE; DRUG HYPERSENSITIVITY; DRUG MECHANISM; DRUG OVERDOSE; HUMAN; HYPERPIGMENTATION; HYPERTENSION; HYPOTENSION; LABORATORY TEST; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PUBLIC HEALTH; TACHYCARDIA; UNITED STATES;

EID: 0035011333     PISSN: 01960644     EISSN: None     Source Type: Journal    
DOI: 10.1067/mem.2001.114315     Document Type: Article

References (53)

1. Clinical features and management of cyanide poisoning
2. Bhopal tragedy's health effects. A review of methyl isocyanate toxicity
3. Hazardous materials incidents: The Washington poison center experience and approach to exposure assessment
4. Epidemiology of hazardous materials responses by Massachusetts district HAZMAT teams
5. Emergency department impact of the Oklahoma City terrorist bombing
6. Chemical warfare agents: Emergency medical and emergency public health issues
7. Report on 640 victims of the Tokyo subway sarin attack
8. Cyanide and methemoglobin kinetics in smoke inhalation victims treated with the cyanide antidote kit
9. Antidotal use of methemoglobin forming cyanide antagonists in concurrent carbon monoxide/cyanide intoxication
10. Unintentional carbon monoxide-related deaths in the United States, 1979 through 1988
11. Elevated blood cyanide concentrations in victims of smoke inhalation
12. Combined carbon monoxide and cyanide poisoning: A place for treatment
13. The clinical experience of acute cyanide poisoning
14. Insufficient stocking of poisoning antidotes in hospital pharmacies
15. On-site availability of selected antidotes: Results of a survey of Massachusetts hospitals
16. Survey of the stocking of poison antidotes in Alabama hospitals
17. Availability of antidotes in rural and urban hospitals in Tennessee
18. Clinical applications of commonly used contemporary antidotes. A US perspective
19. The treatment of cyanide poisoning in children
20. Antidotal efficacy of vitamine B12 a (hydroxocobalamin) in experimental cyanide poisoning
21. Cobalt compounds as antidote for hydrocyanic acid
22. Acute hydrocyanic acid intoxication. Current data on the metabolism of cyanide and treatment by hydroxocobalamin
23. 1998 Annual report of the American association of poison control centers toxic exposure surveillance system
24. Monitoring of cyanocobalamin and hydroxocobalamin during treatment of cyanide intoxication
25. Pharmacokinetics of hydroxocobalamin in smoke inhalation victims
26. Simultaneous determination of hydroxocobalamin and its cyanide complex cyanocobalamin in human plasma by high-performance liquid chromatography. Application to pharmacokinetic studies after high-dose hydroxocobalamin as an antidote for severe cyanide poisoning
27. Pharmacokinetics of hydroxocobalamin in dogs
28. Hydroxocobalamin as a cyanide antidote: Safety, efficacy and pharmacokinetics in heavily smoking normal volunteers
29. Effect of the cyanide antidote hydroxocobalamin on commonly ordered serum chemistry studies
30. Anaphylactic reaction to hydroxycobalamin
31. Syncope following intramuscular injection of hydroxocobalamin in a paraplegic patient: Indication for oral administration of cyanocobalamin in spinal cord injury patients
32. Anaphylactoid reaction to hydroxycobalamin with tolerance of cyanocobalamin
33. Hemodynamic effects of hydroxocobalamin in conscious dogs
34. Comparison of the hemodynamic effects of hydroxocobalamin and cobalt edetate at equipotent cyanide antidotal doses in conscious dogs
35. Study of the mechanisms involved in hydroxocobalamin interference with determination of some biochemical parameters
36. Hydroxo-cobalamine and acute cyanide poisoning in dogs
37. Hydroxocobalamin therapy of cyanide intoxication in guinea pigs
38. Thiosulphate and hydroxocobalamin prophylaxis in progressive cyanide poisoning in guinea-pigs
39. Prevention of nitroprusside-induced cyanide toxicity with hydroxocobalamin
40. Use of vitamin B12 in the treatment and prevention of nitroprusside-induced cyanide toxicity
41. Hydroxycobalamin/sodium thiosulfate as a cyanide antidote
42. Emergency physicians and biological terrorism
43. Preparing hospitals for toxicological mass casualties events